Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease
- 1 December 1992
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 121 (6), 924-926
- https://doi.org/10.1016/s0022-3476(05)80343-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- ENDOTHELIAL CELL ACTIVATION AND HIGH INTERLEUKIN-1 SECRETION IN THE PATHOGENESIS OF ACUTE KAWASAKI DISEASEThe Lancet, 1989
- Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokinesThe FASEB Journal, 1989
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.JCI Insight, 1989
- The Neutrophil-Activating Protein (NAP-1) Is Also Chemotactic for T LymphocytesScience, 1989
- Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.Proceedings of the National Academy of Sciences, 1987
- Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.The Journal of Experimental Medicine, 1986
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986